Inactive Instrument

All News Obalon Therapeutics Inc Nasdaq

Equities

US67424L1008

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

North American Morning Briefing : Big Banks Kick -2-	Apr. 12	DJ
Transcript : ReShape Lifesciences Inc., Q4 2023 Earnings Call, Apr 01, 2024	Apr. 01
ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update	Apr. 01	AQ
ReShape Lifesciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 01	CI
Certain Restricted Stock Units of ReShape Lifesciences Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2024.	Mar. 29	CI
Certain Warrants of ReShape Lifesciences Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2024.	Mar. 29	CI
Certain Options of ReShape Lifesciences Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2024.	Mar. 29	CI
Certain Common Stock of ReShape Lifesciences Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2024.	Mar. 29	CI
ReShape Lifesciences Gets US Patent for Intragastric Balloon Weight-Loss System	Mar. 28	MT
ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System	Mar. 28	AQ
ReShape Lifesciences Receives Notice of Allowance for Additional U.S. Patent Related to Intragastric Balloon System	Mar. 28	CI
ReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band® 2.0 FLEX	Mar. 04	AQ
ReShape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band® 2.0 FLEX	Feb. 22	AQ
Reshape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band 2.0 Flex	Feb. 22	CI
ReShape Lifesciences® Conducts Bariatric Fellows Training for its Lap-Band® System, Highlighting the Next-Generation Lap-Band® 2.0 FLEX	Jan. 24	AQ
ReShape Lifesciences announces FDA PMA supplement approval for next-gen Lap-Band 2.0 Flex	Dec. 21	AQ
ReShape Lifesciences® Engages Maxim Group LLC To Identify Strategic M&A Partnership Alternatives	Dec. 20	AQ
Top Midday Gainers	Dec. 13	MT
North American Morning Briefing : Traders Await FOMC, Powell	Dec. 13	DJ
ReShape Lifesciences® Receives FDA PMA Supplement Approval for its Next-Generation Lap-Band® 2.0 FLEX	Dec. 12	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Obalon Therapeutics Inc Nasdaq

Equities

US67424L1008

All News

Filters